Search

Author/Creator Eshghi, P.

1. A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency. (November 2015)

Authors:
Faranoush, M.; Abolghasemi, Hassan; Toogeh, Gh.; Karimi, M.; Eshghi, P.; Managhchi, M.; Hoorfar, H.; Dehdezi, B. Keikhaei; Mehrvar, A.; Khoeiny, B.; Kamyar, K.; Heshmat, R.; Baghaeipour, M. R.; Mirbehbahani, N. B.; Fayazfar, R.; Ahmadinejad, M.; Naderi, M.
Journal:
Clinical and applied thrombosis/hemostasis
Issue:
Volume 21:Number 8(2015)
Page Start:
724
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor. (March 2016)

Authors:
Faranoush, M.; Abolghasemi, H.; Mahboudi, F.; Toogeh, Gh.; Karimi, M.; Eshghi, P.; Managhchi, M.; Hoorfar, H.; Dehdezi, B. Keikhaei; Mehrvar, A.; khoeiny, B.; Vaziri, B.; Kamyar, K.; Heshmat, R.; Baghaeipour, M. R.; Mirbehbahani, N. B.; Fayazfar, R.; Ahmadinejad, M.; Naderi, M.
Journal:
Clinical and applied thrombosis/hemostasis
Issue:
Volume 22:Number 2(2016)
Page Start:
184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study. Issue 4 (24th April 2017)

Authors:
Kavakli, K.; Demartis, F.; Karimi, M.; Eshghi, P.; Neme, D.; Chambost, H.; Sommer, L.; Zak, M.; Benson, G.
Journal:
Haemophilia
Issue:
Volume 23:Issue 4(2017)
Page Start:
575
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗